Table 3 Adverse events
Event | Metoclopramide group | Domperidone group | Control group | P value |
|---|---|---|---|---|
( n = 100) | ( n = 99) | ( n = 99) | ||
Any event | 20 (20.0) | 10 (10.1) | 13 (13.1) | 0.126 |
Drug-associated events | Â | Â | Â | Â |
 Lethargy | 2 (2.0) | 0 | 0 | 0.136 |
 Dysphoria | 1 (1.0) | 0 | 0 | 0.370 |
 Amyostasia | 1 (1.0) | 0 | 0 | 0.370 |
 Pruritus | 0 | 1 (1.0) | 0 | 0.365 |
Tube-associated events | Â | Â | Â | Â |
 Nasal mucosa bleeding | 8 (8.0) | 5 (5.1) | 8 (8.1) | 0.637 |
 Airway misplacement | 1 (1.0) | 0 | 1 (1.0) | 0.606 |
 Pain | 2 (2.0) | 3 (3.0) | 2 (2.0) | 0.861 |
 Nausea | 4 (4.0) | 1 (1.0) | 1 (1.0) | 0.222 |
 Vomiting | 1 (1.0) | 1 (1.0) | 1 (1.0) | 1.000 |